The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cyclin D1 is a nuclear protein required for cell cycle progression in G1
Baldin, V, Lukas, J., Marcote, M. J., Pagano, M., & Draetta, G. (1993) · Genes & Development · doi:10.1101/gad.7.5.812 · Cited by 1,614
Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane)
Singh, S., & Aggarwal, B. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.24995 · Cited by 1,386
Self-citationNF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1
Guttridge, D. C., Albanese, C., Reuther, J. Y., Pestell, R. G., & Baldwin, A. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5785 · Cited by 1,312
D-type cyclin-dependent kinase activity in mammalian cells.
Matsushime, H., Quelle, D. E., Shurtleff, S. A., Shibuya, M., Sherr, C. J., & Kato, J. Y. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.2066 · Cited by 1,064
Sherr, C. J. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89005-2 · Cited by 980 · cited 2×
“These kinases then phosphorylate the retinoblastoma protein and thus advance through the G1 phase of the cell cycle (Sherr, 1995), leading to stimulation of DNA synthesis.”
BackgroundMammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
Wang, T. C., Cardiff, R. D., Zukerberg, L., Lees, E., Arnold, A., & Schmidt, E. V. (1994) · Nature · doi:10.1038/369669a0 · Cited by 965
Specific protection against breast cancers by cyclin D1 ablation
Yu, Q., Geng, Y., & Sicinski, P. (2001) · Nature · doi:10.1038/35082500 · Cited by 934
Transforming p21 Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions
Albanese, C., Johnson, J., Watanabe, G., Eklund, N., Vu, D., Arnold, A., & Pestell, R. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23589 · Cited by 803
Hinz, M., Krappmann, D., Eichten, A., Heder, A., Scheidereit, C., & Strauss, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2690 · Cited by 788
Gillett, C., Fantl, V., Smith, D., Fisher, C., Bartek, J. J., Dickson, C., Barnes, D. M., & Peters, G. (1994) · PubMed · Cited by 750
Diehl, J. A., Zindy, F., & Sherr, C. J. (1997) · Genes & Development · doi:10.1101/gad.11.8.957 · Cited by 746 · cited 2×
“Inasmuch as cyclinD1 undergoes ubiquitindependent proteosomal degradation (Diehl et al., 1997), and lactacystin inhibits the 26 S proteosome (Vrana and Grant, 2001), we examined the ability of lactacystin to block curcumin-induced degradation of cyclin D1 in LNCaP cell.”
BackgroundMice lacking cyclin D1 are small and show defects in eye and mammary gland development.
Fantl, V, Stamp, G., Andrews, A., Rosewell, I., & Dickson, C. (1995) · Genes & Development · doi:10.1101/gad.9.19.2364 · Cited by 691
Jobin, C., Bradham, C. A., Russo, M. P., Juma, B., Narula, A. S., Brenner, D. A., & Sartor, R. B. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.6.3474 · Cited by 681
Molecular mechanisms underlying ErbB2/HER2 action in breast cancer
Harari, D., & Yarden, Y. (2000) · Oncogene · doi:10.1038/sj.onc.1203973 · Cited by 633
Plummer, S. M., Holloway, K. A., Manson, M. M., Munks, R. J., Kaptein, A., Farrow, S., & Howells, L. (1999) · Oncogene · doi:10.1038/sj.onc.1202980 · Cited by 628
Cyclin D1 protein expression and function in human breast cancer
Bartkova, J., Lukas, J., Müller, H., Lützhøt, D., Strauss, M., & Bartek, J. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570311 · Cited by 509
Anto, R. J. (2002) · Carcinogenesis · doi:10.1093/carcin/23.1.143 · Cited by 429
Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells
Kuo, M.-L., Huang, T.-S., & Lin, J.-K. (1996) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(96)00032-4 · Cited by 404
Antiproliferative effect of curcumin (diferuloylmethane) against human breast tumor cell lines
Mehta, K., Pantazis, P., McQueen, T., & Aggarwal, B. B. (1997) · Anti-Cancer Drugs · doi:10.1097/00001813-199706000-00010 · Cited by 347
Self-citationLee, R. J., Albanese, C., Fu, M., D'Amico, M., Lin, B., Watanabe, G., Haines, G. K., Siegel, P. M., Hung, M.-C., Yarden, Y., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.2.672-683.2000 · Cited by 347
Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis
Arber, N., Hibshoosh, H., Moss, S., Sutter, T., Zhang, Y., Begg, M., Wang, S., Weinstein, I., & Holt, P. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8608874 · Cited by 313
Joyce, D., Bouzahzah, B., Fu, M., Albanese, C., D'Amico, M., Steer, J., Klein, J. U., Lee, R. J., Segall, J. E., Westwick, J. K., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25245 · Cited by 287
Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines
Jiang, M., Yang‐Yen, H., Yen, J. J., & Lin, J. (1996) · Nutrition and Cancer · doi:10.1080/01635589609514468 · Cited by 275
Kumar, A., Dhawan, S., Hardegen, N. J., & Aggarwal, B. B. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00557-1 · Cited by 238
Self-citationAbnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer.
Bártková, J., Lukáš, J., Müller, H., von Strauss, M., Gusterson, B. A., & Bartek, J. J. (1995) · PubMed · Cited by 236
Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells
Chen, H., & Huang, H. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701914 · Cited by 231
Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone.
Drobnjak, M., Osman, I., Scher, H. I., Fazzari, M. J., & Cordon‐Cardo, C. (2000) · PubMed · Cited by 221
Bhaumik, S., Anjum, R., Rangaraj, N., Pardhasaradhi, B. V. V., & Khar, A. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00969-2 · Cited by 218
Han, S.-S., Chung, S.-T., Robertson, D. A., Ranjan, D., & Bondada, S. (1999) · Clinical Immunology · doi:10.1006/clim.1999.4769 · Cited by 207
Posttranslational regulation of cyclin D1 by retinoic acid: A chemoprevention mechanism
Langenfeld, J., Kiyokawa, H., Sekula, D., Boyle, J., & Dmitrovsky, E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.12070 · Cited by 202
Regulation by cAMP-dependent protein kinease of a G-protein-mediated phospholipase C
Liu, M., & Simon, M. I. (1996) · Nature · doi:10.1038/382083a0 · Cited by 195
Self-citationInhibitory effect of curcuminoids on MCF-7 cell proliferation and structure–activity relationships
Simon, A., Allais, D. P., Duroux, J. L., Basly, J. P., Durand-Fontanier, S., & Delage, C. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00092-5 · Cited by 194
Chen, H., Zhang, Z., Zhang, Y.-L., & Zhou, D. (1999) · PubMed · Cited by 187
Haridas, V., Darnay, B. G., Natarajan, K., Heller, R. A., & Aggarwal, B. B. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3152 · Cited by 179
Self-citationAmplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer
Dickson, C., Fantl, V., Gillett, C., Brookes, S., Bartek, J., Smith, R., Fisher, C., Barnes, D., & Peters, G. (1995) · Cancer Letters · doi:10.1016/0304-3835(94)03676-a · Cited by 176
Pervin, S., Singh, R., & Chaudhuri, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041603998 · Cited by 176
Differential sensitivity of human mammary epithelial and breast carcinoma cell lines to curcumin
Ramachandran, C., & You, W. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006170224414 · Cited by 159
The PRAD‐1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas
Bártková, J., Lukas, J., Strauss, M., & Bártek, J. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580420 · Cited by 152
Piwocka, K., Zabłocki, K., Wieckowski, M. R., Skierski, J., Feiga, I., Szopa, J., Drela, N., Wojtczak, L., & Sikora, E. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4480 · Cited by 135
Ral GTPases Contribute to Regulation of Cyclin D1 through Activation of NF-κB
Henry, D. O., Moskalenko, S. A., Kaur, K. J., Fu, M., Pestell, R. G., Camonis, J., & White, M. A. (2000) · Molecular and Cellular Biology · doi:10.1128/.20.21.8084-8092.2000 · Cited by 126
Antisense cyclin D1 induces apoptosis and tumor shrinkage in human squamous carcinomas.
Sauter, E. R., Nesbit, M., Litwin, S., Klein–Szanto, A. J., Cheffetz, S., & Herlyn, M. (1999) · PubMed · Cited by 110
Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1
Adélaïde, J., Monges, G., Derderian, C., Seitz, J. F., & Birnbaum, D. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.13 · Cited by 104
A Specific Role for Cyclin D1 in Mammary Gland Development
Siciński, P., & Weinberg, R. A. (1997) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1026391128117 · Cited by 70
Prognostic Role of Cyclin D1 in Lung Cancer: Relationship to Proliferating Cell Nuclear Antigen
Caputi, M., Groeger, A. M., Esposito, V., Dean, C., Luca, A. D., Pacilio, C., Muller, M. R., Giordano, G. G., Baldi, F., Wolner, E., et al. (1999) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.20.4.3366 · Cited by 67
Overexpression of cyclin D1 is rare in human prostate carcinoma
Gumbiner, L. M., Gumerlock, P. H., Mack, P. C., Chi, S.-G., White, R. D., Mohler, J. L., Pretlow, T. G., & Tricoli, J. V. (1999) · The Prostate · doi:10.1002/(sici)1097-0045(19990101)38:1<40::aid-pros5>3.0.co;2-i · Cited by 59
Vrana, J. A., & Grant, S. (2001) · Blood · doi:10.1182/blood.v97.7.2105 · Cited by 34
Cytokine Induction of Nuclear Factor κB in Cycling and Growth-arrested Cells
Duckett, C. S., Perkins, N. D., Leung, K., Agranoff, A. B., & Nabel, G. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.32.18836 · Cited by 32
Cited by
Curcumin: From ancient medicine to current clinical trials
Hatcher, H., Planalp, R., Cho, J., Torti, F. M., & Torti, S. V. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7452-4 · Cited by 1,843
Molecular targets of dietary agents for prevention and therapy of cancer
Aggarwal, B. B., & Shishodia, S. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.02.009 · Cited by 1,754
Self-citationCURCUMIN: THE INDIAN SOLID GOLD
Aggarwal, B. B., Sundaram, C., Malani, N., & Ichikawa, H. (2007) · ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY · doi:10.1007/978-0-387-46401-5_1 · Cited by 1,647
Self-citationKinase-targeted cancer therapies: progress, challenges and future directions
Bhullar, K. S., Lagarón, N. O., McGowan, E. M., Parmar, I., Jha, A., Hubbard, B. P., & Rupasinghe, H. P. V. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0804-2 · Cited by 1,245
Cancer epigenetics reaches mainstream oncology
Rodríguez-Paredes, M., & Esteller, M. (2011) · Nature Medicine · doi:10.1038/nm.2305 · Cited by 1,205
Metadata
- Authors
- Mukhopadhyay, A., Banerjee, S., Stafford, L. J., Xia, C., Liu, M., & Aggarwal, B. B.
- Venue
- Oncogene
- Published
- 2002-12-12
- Volume
- 21
- Issue
- 57
- Pages
- 8852-8861
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2084583180
- Cited by
- 353
- References
- 47
- FWCI
- 6.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.